ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 602

Sexual and Reproductive Health Counseling Among Adolescents with Systemic Lupus Erythematosus

Xue Tian1, Murray H. Passo2, Janice D. Key3, Thomas C. Hulsey4 and Natasha M. Ruth1, 1Pediatric Rheumatology, The Medical University of South Carolina, Charleston, SC, 2Pediatric Rheumatology, Medical University of South Carolina, Charleston, SC, 3Adolescent Medicine, The Medical University of South Carolina, Charleston, SC, 4Pediatrics, The Medical University of South Carolina, Charleston, SC

Meeting: 2012 ACR/ARHP Annual Meeting

Keywords: Adolescent patients, Education, patient, pregnancy and systemic lupus erythematosus (SLE)

  • Tweet
  • Email
  • Print
Session Information

Title: Systemic Lupus Erythematosus: Clinical Aspects

Session Type: Abstract Submissions (ACR)

Background/Purpose: Systemic Lupus Erythematosus (SLE) is an autoimmune disease that is known to target young adults, especially women of child-bearing age. Although it is well-accepted that teratogenic SLE medications can cause negative pregnancy outcomes, there has been little research conducted to examine sexual health and contraceptive counseling among young adults with SLE, specifically teens and adolescents.  The purpose of this study is: 1) to determine how much female adolescents with SLE know about their disease, SLE medications, how SLE relates to their sexual health, and how SLE symptoms can be impacted by pregnancy, STDs and contraceptives containing estrogen. 2) to educate the same group of patients about sexual and reproductive health using a face-to-face counseling session. 3) to reassess their knowledge after the intervention.

Methods: Female adolescents with SLE were recruited from the MUSC Pediatric Rheumatology clinic. Information on age, race, gender, medications, previous pregnancies, and length of diagnosis with SLE was obtained. The questionnaire (31 items regarding SLE medications, contraceptives, and STD’s) was completed by all subjects before and after the intervention, which was a face to face educational session. The resulting data was analyzed by using a paired t-test.

Results: 13 female SLE patients, ages 12-21, were studied (11 African Americans, 1 Caucasian, 1 other). The average percent correct on the pretest questions was 30.8% on questions regarding the effects of SLE medications on pregnancy, 38.8% on questions regarding contraceptives, and 78.8% on questions regarding sexual health and STD’s. The average percent correct on post-tests for those 3 categories of questions were 88%, 77%, and 99% respectively. The average improvement between pre- and post-tests for the 3 categories were 57.7% with a p-value of 0.0001, 46.2% with p-value of 0.0001, and 20.2% with p-value of 0.0006 respectively.

Conclusion: The low scores on the initial baseline assessment show that SLE adolescents are under-educated about contraceptives and the effects of SLE medications on pregnancy. After the counseling session, the average percent correct scores on the post-test significantly improved in all 3 categories. The issues surrounding contraceptives and pregnancy are important for this population, and it is imperative to advise SLE adolescents and teens on effective contraceptives in order to avoid unplanned pregnancies with unfavorable outcomes. This study demonstrates the need to establish routine counseling on contraceptives and reproductive health for women with SLE.


Disclosure:

X. Tian,
None;

M. H. Passo,
None;

J. D. Key,
None;

T. C. Hulsey,
None;

N. M. Ruth,
None.

  • Tweet
  • Email
  • Print

« Back to 2012 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/sexual-and-reproductive-health-counseling-among-adolescents-with-systemic-lupus-erythematosus/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology